blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4139362

EP4139362 - PD-1 AGONIST MULTIMERIC BINDING MOLECULES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.01.2023
Database last updated on 13.11.2024
FormerThe international publication has been made
Status updated on  29.10.2021
Most recent event   Tooltip05.06.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
IGM Biosciences Inc.
325 E. Middlefield Road
Mountain View, CA 94043 / US
[2023/09]
Inventor(s)01 / KEYT, Bruce
IGM Biosciences, Inc. 325 East Middlefield Road
Mountain View, California 94043 / US
02 / METZGER, Todd
IGM Biosciences, Inc. 325 East Middlefield Road
Mountain View, California 94043 / US
03 / SINCLAIR, Angus
IGM Biosciences, Inc. 325 East Middlefield Road
Mountain View, California 94043 / US
 [2023/09]
Representative(s)Inspicos P/S
Agern Allé 24
2970 Hørsholm / DK
[2023/09]
Application number, filing date21792296.221.04.2021
[2023/09]
WO2021US28459
Priority number, dateUS202063014023P22.04.2020         Original published format: US 202063014023 P
US202063050413P10.07.2020         Original published format: US 202063050413 P
US202163144708P02.02.2021         Original published format: US 202163144708 P
[2023/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2021216756
Date:28.10.2021
Language:EN
[2021/43]
Type: A2 Application without search report 
No.:EP4139362
Date:01.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.10.2021 takes the place of the publication of the European patent application.
[2023/09]
Search report(s)International search report - published on:US02.12.2021
ClassificationIPC:C07K16/28, A61K39/395, A61P29/00, A61P37/04, A61P37/06
[2024/17]
CPC:
C07K16/2818 (EP,IL,KR,US); A61P37/00 (KR); A61P37/06 (EP);
A61K2039/505 (KR); C07K2317/35 (EP,IL,KR,US); C07K2317/52 (EP,US);
C07K2317/565 (US); C07K2317/75 (EP,IL,KR,US); C07K2317/92 (EP,IL,KR,US);
C07K2317/94 (EP,US) (-)
Former IPC [2023/09]C07K16/28, A61P29/00, A61K39/00, A61P37/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/09]
TitleGerman:MULTIMERE PD-1-AGONIST-BINDUNGSMOLEKÜLE[2023/09]
English:PD-1 AGONIST MULTIMERIC BINDING MOLECULES[2023/09]
French:MOLÉCULES DE LIAISON MULTIMÈRES AGONISTES DE PD-1[2023/09]
Entry into regional phase22.11.2022National basic fee paid 
22.11.2022Search fee paid 
22.11.2022Designation fee(s) paid 
22.11.2022Examination fee paid 
Examination procedure22.11.2022Examination requested  [2023/09]
26.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
20.04.2023Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.202404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2007154469  (IRIE REIKO [JP]);
 [Y]WO2011110604  (UCB PHARMA SA [BE], et al);
 [YYY]WO2018017889  (IGM BIOSCIENCES INC [US]);
 [YY]US2019270818  (YACHI PIA PAULIINA [US], et al);
 [Y]WO2019169314  (IGM BIOSCIENCES INC [US]);
 [PXPXP]WO2020086745  (IGM BIOSCIENCES INC [US]);
by applicantUS4683195
 US5585089
 US5693761
 US5693762
 US5892019
 US5939598
 US6180370
 WO2017196867
 US2018009897
 US9938347
 US9951134
 US2018118816
 US2018118814
 US2018265596
 WO2018187702
 US2019002566
 US2019100597
 US2019185570
 US10351631
 WO2019165340
 US10400038
 WO2019169314
 US2019330374
 US2019330360
 US2019338040
 US2019338041
 US19630628912
 WO2019US57702
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.